Twist Bioscience Corp. (TWST)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$142.58+1.63%
Close 2026-11-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · TWST
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 11.0% |
| Our one-year growth estimate | diamond | 23.5% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 12.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name operates in a high-miss-rate industry and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
TWST — earnings miss
Dated 2026-08-03
Results of Operations and Financial Condition. On August 3, 2026, Twist Bioscience Corporation (the “ Company ”) issued a press release announcing its financial results for the quarter ended June 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Se…
Why it matters: Twist raised its revenue range to $456 million to $457 million. Meeting or beating it would extend its run of growth.
Supportive ifFY26 revenue is at least $456 million, and Q4 revenue is at least $123 million.
Worry ifFY26 revenue is below $456 million or Q4 revenue is below $123 million.
Why it matters: Management said NGS would return to 20% growth by Q4. Results near or above that mark would support the stated growth plan.
Supportive ifQ4 NGS revenue grows at least 20% year over year.
Worry ifQ4 NGS revenue grows less than 20% year over year.
Why it matters: Gross margin rose to 52.8% in Q3, above the full-year goal. Staying above 52% would keep that goal on track.
Supportive ifFY26 gross margin is above 52%.
Worry ifFY26 gross margin is 52% or lower.
Why it matters: Twist has kept this target while adjusted EBITDA losses narrowed from $13.3 million to $11.3 million. Reaching zero would meet a key goal.
Supportive ifIn Q4 FY26 results, adjusted EBITDA is zero or higher.
Worry ifIn Q4 FY26 results, adjusted EBITDA is still below zero.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$335 on $10,000 · ±3.3% | How much price usually moves either way. |
| Bad day | $710 loss on $10,000 · 7.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,705 loss on $10,000 · 37.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.